due to SCD, the majority because of ventricular arrhythmia (VA). 4 It is possible to protect patients who are at risk for life-threatening VA and subsequent SCD with the implantation of the implantable cardioverter defibrillator (ICD). 5, 6 A low left ventricular ejection fraction (LVEF) is considered to be the most important risk factor in these cases. LVEF measured at rest has an important impact on long-term prognosis. The frequency of SCD increases with a decrease in LVEF. 7 ICD implantation improved survival in patients with a prior myocardial infarction and an LVEF <30% in compared to conventional pharmacological treatment (amiodarone). 6 ICD showed superior result in patients group with all-cause cardiomyopathy in combination with mild to moderate heart failure (NYHA class II or III) and an LVEF <35% than antiarrhythmic group. 8 These results form the basis of the current ACC/ AHH/ESC guidelines for the management of patients with VA and prevention of SCD. In these guidelines, the use of echocardiography is advised to measure LVEF. 9 Twodimensional echocardiography is the most widely used method to assess LVEF. This technique allows real-time imaging of the function and anatomy of the heart, is readily available, inexpensive and non-invasive. Important limitations are its operator dependency, acoustic window dependency, moderate reproducibility and accuracy. 8, 9 When accurate assessment by echocardiography is not feasible, other imaging modalities can be used. 9 radionuclide ventriculography (RV) or computed tomography (CT). In echocardiography, measurement of LVEF varies operator to operator. Sometime cardiologists use geometric assumption while doing echo which is variable. So CMR is very useful in Cardiomyopathy. 12, 13 The reproducibility and accuracy of LVEF calculation by CMR are higher than echocardiography both in normal and dilated heart. 12, 14, 15 Calculation of LVEF by RV has been used for more than two decades. Advantages of RV include high reproducibility and low inter and intraobserver variability. 16, 17 In 95% of the cases, results of repeated quantitative radionuclide assessment of LVEF can be expected to be within a 2% and 4% range. By using the CT, calculation LVEF takes about ten minutes which is faster. This technique is useful in both normal and abnormal hearts. Its reproducibility and accuracy is comparable with the accuracy of CMR. But CT is limited by radiation exposure and the use of iodated contrast material with additional risks. 18 CMR can detect particular area of fibrosis whether it is regional or mid layer of myocardium in late gadolinium enhancement stage. Regional fibrosis indicates myocardial infarction and global mid layer of fibrosis suggests cardiomyopathy.
Cardiac MRI protocol:
Prior to ICD implantation, patients may underwent CMR. Cine images were acquired with a steady-state free precession pulse sequence (TR 2.5-3.8, TE 1.1-1.6, average in-plane resolution 1.5×2.4 mm, flip angle 45-60º, temporal resolution 40-45 msec) in long-axis planes and contiguous 8-mm short-axis slices from the mitral annulus to the apex. Fifteen to thirty minutes after intravenous administration of 0.2 mmol/kg gadodiamide, delayed contrast enhanced images can be acquired using inversion-recovery fast gradient-echo pulse sequences in the same short-axis locations as the cine images. In order to exclude artifact, short axis imaging was repeated in 2 different phaseencoding directions and cross-sectional long axis views were also acquired. Imaging parameters were: TR 5.4-8.3 ms, TE 1.3-3.9 ms, average in-plane spatial resolution 1.4-1.5×2.2-2.4 mm, 8-mm slice thickness, 2-mm gap, TI 175-300 msec (adjusted as needed in the delayed enhancement image acquisitions to optimally null the signal of normal myocardium), 1-2 R-R imaging, flip angle 20-25°. 19 
Conclusion:
The presence of CMR LGE identifies a group of NICM patients with an eightfold higher risk of an index composite outcome of heart failure hospitalization, appropriate action of ICD and cardiac death, compared to patients without LGE. CMR scanning and interpretation are relatively straightforward and can be performed at many hospitals which routinely provide care for patients with heart disease. Future more research will be needed to determine CMR findings can lower morbidity and mortality for patients with nonischemic cardiomyopathy by considering ICD or CRT or left ventricular assist device placement. As these devices are expensive it would be cost effective if correct selection of patients. 
